Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 2
1992 2
1993 2
1994 1
1995 4
1996 2
1997 3
1998 6
1999 2
2000 2
2001 1
2002 4
2003 3
2004 5
2005 5
2007 3
2008 3
2009 5
2010 1
2011 3
2012 4
2013 4
2014 5
2015 1
2016 2
2017 3
2018 3
2019 4
2020 3
2021 5
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for time de mulder
Search for Tine De Mulder instead (1 results)
Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924.
Sternberg CN, de Mulder PH, Schornagel JH, Théodore C, Fossa SD, van Oosterom AT, Witjes F, Spina M, van Groeningen CJ, de Balincourt C, Collette L; European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. Sternberg CN, et al. Among authors: de mulder ph. J Clin Oncol. 2001 May 15;19(10):2638-46. doi: 10.1200/JCO.2001.19.10.2638. J Clin Oncol. 2001. PMID: 11352955 Clinical Trial.
There was no statistically significant difference in survival (P =.122) or time to progression (P =.114). Progression-free survival was significantly better with HD-MVAC (P=.037; hazard ratio.75; 95% CI.58 to.98). The median progression-free survival time was 9.1 mo …
There was no statistically significant difference in survival (P =.122) or time to progression (P =.114). Progression-free survival w …
Electrodiagnostic Abnormalities Associated with Fibromyalgia.
Hulens M, Bruyninckx F, Rasschaert R, Vansant G, De Mulder P, Stalmans I, Bervoets C, Dankaerts W. Hulens M, et al. Among authors: de mulder p. J Pain Res. 2020 Apr 9;13:737-744. doi: 10.2147/JPR.S234475. eCollection 2020. J Pain Res. 2020. PMID: 32308473 Free PMC article.
S3-S4 nerve-supplied anal reflexes were delayed in 94%. CONCLUSION: This is the first time that electrodiagnostic data of both lumbar and sacral nerve root myotomes in fibromyalgia patients are presented. ...
S3-S4 nerve-supplied anal reflexes were delayed in 94%. CONCLUSION: This is the first time that electrodiagnostic data of both lumbar …
Delayed emesis following anticancer chemotherapy.
Kris MG, Roila F, De Mulder PH, Marty M. Kris MG, et al. Among authors: de mulder ph. Support Care Cancer. 1998 May;6(3):228-32. doi: 10.1007/s005200050158. Support Care Cancer. 1998. PMID: 9629874 Review.
Hydrocephalus associated with multiple Tarlov cysts.
Hulens M, Dankaerts W, Rasschaert R, Bruyninckx F, Stalmans I, Vansant G, De Mulder P. Hulens M, et al. Among authors: de mulder p. Med Hypotheses. 2019 Sep;130:109293. doi: 10.1016/j.mehy.2019.109293. Epub 2019 Jun 27. Med Hypotheses. 2019. PMID: 31383334
In this paper, we describe a case report that provides evidence for this hypothesis. A 30-year-old man presented for the first time in our clinic complaining of lower back, leg, thoracic, neck, and arm pain; headaches; and bladder, bowel, and sphincter symptoms. ...
In this paper, we describe a case report that provides evidence for this hypothesis. A 30-year-old man presented for the first time i …
Postoperative outcomes and quality of life following hysterectomy by natural orifice transluminal endoscopic surgery (NOTES) compared to laparoscopy in women with a non-prolapsed uterus and benign gynaecological disease: a systematic review and meta-analysis.
Baekelandt J, De Mulder PA, Le Roy I, Mathieu C, Laenen A, Enzlin P, Weyers S, Mol BW, Bosteels JJ. Baekelandt J, et al. Among authors: de mulder pa. Eur J Obstet Gynecol Reprod Biol. 2017 Jan;208:6-15. doi: 10.1016/j.ejogrb.2016.10.044. Epub 2016 Oct 29. Eur J Obstet Gynecol Reprod Biol. 2017. PMID: 27880893 Review.
The study quality as assessed by the Newcastle-Ottawa scale was acceptable. Both studies reported no conversions. The operative time in women treated by NOTES was shorter compared to LAVH: the mean difference (MD) was -22.04min (95% CI -28.00min to -16.08min; 342 women; 2 …
The study quality as assessed by the Newcastle-Ottawa scale was acceptable. Both studies reported no conversions. The operative time …
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG).
Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH, Horwich A, Oliver T, Huddart R, Rosti G, Paz Ares L, Pont O, Hartmann JT, Aass N, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Classen J, Clemm S, Culine S, de Wit M, Derigs HG, Dieckmann KP, Flasshove M, Garcia del Muro X, Gerl A, Germa-Lluch JR, Hartmann M, Heidenreich A, Hoeltl W, Joffe J, Jones W, Kaiser G, Klepp O, Kliesch S, Kisbenedek L, Koehrmann KU, Kuczyk M, Laguna MP, Leiva O, Loy V, Mason MD, Mead GM, Mueller RP, Nicolai N, Oosterhof GO, Pottek T, Rick O, Schmidberger H, Sedlmayer F, Siegert W, Studer U, Tjulandin S, von der Maase H, Walz P, Weinknecht S, Weissbach L, Winter E, Wittekind C; European Germ Cell Cancer Consensus Group. Schmoll HJ, et al. Among authors: de mulder ph. Ann Oncol. 2004 Sep;15(9):1377-99. doi: 10.1093/annonc/mdh301. Ann Oncol. 2004. PMID: 15319245 Free article. Review.
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.
Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, del Muro XG, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, Kuczyk M, Laguna P, Galvis OL, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Ares LP, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H. Krege S, et al. Among authors: de mulder ph. Eur Urol. 2008 Mar;53(3):478-96. doi: 10.1016/j.eururo.2007.12.024. Epub 2007 Dec 26. Eur Urol. 2008. PMID: 18191324 Review.
OBJECTIVES: The first consensus report presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in the year 2004 has found widespread approval by many colleagues throughout the world. In November 2006, the group met a second time under the auspices of the Depart …
OBJECTIVES: The first consensus report presented by the European Germ Cell Cancer Consensus Group (EGCCCG) in the year 2004 has found widesp …
Breast cancer subtype and survival by parity and time since last birth.
De Mulder H, Laenen A, Wildiers H, Punie K, Poppe A, Remmerie C, Lefrère H, Nevelsteen I, Smeets A, Van Nieuwenhuysen E, Han S, Van Limbergen E, Floris G, Vergote I, Neven P. De Mulder H, et al. Breast Cancer Res Treat. 2018 Jun;169(3):481-487. doi: 10.1007/s10549-018-4701-6. Epub 2018 Feb 10. Breast Cancer Res Treat. 2018. PMID: 29426984
Primary study endpoints were the breast cancer subtype, disease-free survival, and distant disease-free survival by parity and time since last birth. Statistical methods used were baseline-category logits models and Cox proportional hazard models. ...RESULTS: Breast cancer …
Primary study endpoints were the breast cancer subtype, disease-free survival, and distant disease-free survival by parity and time s …
Estimating age-at-death in burnt adult human remains using the Falys-Prangle method.
Veselka B, Hlad M, Wolfe Steadman D, Annaert H, Boudin M, Capuzzo G, Dalle S, Kontopoulos I, De Mulder G, Sabaux C, Salesse K, Sengeløv A, Stamataki E, Vercauteren M, Tys D, Snoeck C. Veselka B, et al. Among authors: de mulder g. Am J Phys Anthropol. 2021 May;175(1):128-136. doi: 10.1002/ajpa.24210. Epub 2020 Dec 31. Am J Phys Anthropol. 2021. PMID: 33381868
Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma.
van Herpen CM, De Mulder PH. van Herpen CM, et al. Among authors: de mulder ph. Crit Rev Oncol Hematol. 2002 Mar;41(3):327-34. doi: 10.1016/s1040-8428(01)00173-1. Crit Rev Oncol Hematol. 2002. PMID: 11880208 Review.
On the basis of a number of prognostic factors, such as performance score, time between the initial diagnosis and the treatment of metastases and the number of metastatic sites, patients can be divided in different prognostic groups. ...
On the basis of a number of prognostic factors, such as performance score, time between the initial diagnosis and the treatment of me …
89 results